Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2006-09-26
2006-09-26
O'Hara, Eileen B. (Department: 1646)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S069100, C435S320100, C435S361000, C435S369000, C530S350000, C536S023500, C536S023400
Reexamination Certificate
active
07112421
ABSTRACT:
Disclosed are nucleic acids encoding BAFF-R polypeptides, as well as antibodies to BAFF-R polypeptides and pharmaceutical compositions including same. Methods of treating tumorigenic and autoimmune conditions using the nucleic acids, polypeptides, antibodies and pharmaceutical compositions of this invention are also provided.
REFERENCES:
patent: 5969102 (1999-10-01), Bram et al.
patent: 6297367 (2001-10-01), Tribouley
patent: 6316222 (2001-11-01), Bram et al.
patent: 6475986 (2002-11-01), Aggarwal
patent: 6475987 (2002-11-01), Shu
patent: 6541224 (2003-04-01), Yu et al.
patent: 6551795 (2003-04-01), Rubenfield et al.
patent: 2002/0037852 (2002-03-01), Browning et al.
patent: 2002/0165156 (2002-11-01), Browning et al.
patent: 2002/0172674 (2002-11-01), Browning et al.
patent: 2003/0023038 (2003-01-01), Rennert et al.
patent: 2003/0082175 (2003-05-01), Scneider et al.
patent: 2003/0092164 (2003-05-01), Gross et al.
patent: 2003/0095967 (2003-05-01), MacKey et al.
patent: 2003/0194743 (2003-10-01), Beltzer et al.
patent: 0 869 180 (1998-10-01), None
patent: WO 97/33902 (1997-09-01), None
patent: WO 98/18921 (1998-05-01), None
patent: WO 98/27114 (1998-06-01), None
patent: WO 98/39361 (1998-09-01), None
patent: WO 98/55620 (1998-12-01), None
patent: WO 98/55621 (1998-12-01), None
patent: WO 99/04001 (1999-01-01), None
patent: WO 99/11791 (1999-03-01), None
patent: WO 99/12964 (1999-03-01), None
patent: WO 99/12965 (1999-03-01), None
patent: WO 99/33980 (1999-07-01), None
patent: WO 00/26244 (2000-05-01), None
patent: WO 00/39295 (2000-07-01), None
patent: WO 00/40716 (2000-07-01), None
patent: WO 00/43032 (2000-07-01), None
patent: WO 00/50597 (2000-08-01), None
patent: WO 00/50633 (2000-08-01), None
patent: WO 00/58362 (2000-10-01), None
patent: WO 01/12812 (2001-02-01), None
patent: WO 01/24811 (2001-04-01), None
patent: WO 02/02641 (2002-01-01), None
patent: WO 02/18620 (2002-03-01), None
patent: WO 02/38766 (2002-05-01), None
patent: WO 02/092620 (2002-11-01), None
patent: WO 03/014294 (2003-02-01), None
patent: WO 03/024991 (2003-03-01), None
patent: WO 03/035846 (2003-05-01), None
patent: WO 03/055979 (2003-07-01), None
patent: WO 04/035735 (2004-04-01), None
patent: WO 05/005462 (2005-01-01), None
Kashii, Y. et al.,“Constitutive Expression and Role of the TNF Family Ligands in Apoptotic Killing of Tumor Cells by Human NK Cells,”J. Immunol. 163:5358-66 (1999).
von Bulow & Bram, “NT-AT Activation Induced by a CAML-Interacting Member of the Tumor Necrosis Factor Receptor Superfamily,”Science 278:138-141 (1997).
Ward, P. and Mulligan, M. “Blocking of Adhesion Molecules in Vivo as Anti-Imflammatory Therapy,”Ther. Immunol. 1:165-71 (1994).
Ware, C., “April and Baff Connect Autoimmunity and Cancer,”J. Exp. Med. 192:F35-F37 (2000).
Partial International Search Report for International Application No. PCT/US01/28006, mailed Sep. 6, 2002.
International Search Report for International Application No. PCT/US01/28006, mailed Mar. 28, 2003.
Database Accession No. AI250289, XP002206618.
Database Accession No. Z99716.4, XP00206619.
Domingues, H.M., “Rational Design Strategies to Improve Cytokine Foldability and Minimization of a Functional Motif: The IL-4 Case”Thesis University of Utrecht, p. 48, line 25-p. 51, line 6, p. 94; table III (1999).
Gross et al., “TACI and BCMA Are Receptors for a TNF Homologue Implicated in B-Cell Autoimmune Disease”Nature, 404:995-999 (2000).
Kwon et al., “Single Amino Acid Substitutions of α1—Antitrypsin That Confer Enhancement in Thermal Stability”J. Biol. Chem., 269:9627-9631 (1994).
Marsters et al., “Interaction of the TNF Homologues BLyS and APRIL with TNF Receptor Homologues BCMA and TACI”Curr. Biol., 10:785-788 (2000).
Schein, C.H., “Production of Soluble Recombinant Proteins in Bacteria”Biotechnology, 7:1141-1149 (1989).
Schiemann et al., “An Essential Role for BAFF in the Normal Development of B Cells Through a BCMA-Independent Pathway”Science, 293:2111-2114 (2001).
Schneider et al., “BAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell Growth”J. Exp. Med., 189:1747-1756 (1999).
Thompson et al., “BAFF Binds to the Tumor Necrosis Factor Receptor-Like Molecule B Cell Maturation Antigen and is Important for Maintaining the Peripheral B Cell Population”J. Exp. Med, 192:129-135 (2000).
Thomposon et al., “BAFF-R, a Newly Identified TNF Receptor That Specifically Interacts with BAFF”Science, 293:2108-2111 (2001).
Waldschmidt et al., “Long Live the Mature B-Cell—A Baffling Mystery Resolved”Science, 293:2012-2013 (2001).
Wood et al., “Prolines and Amyloidogencity in Fragments of the Alzheimer's Peptide β/A4”Biochemistry, 34:724-730 (1995).
Yan et al., “Identification of a Novel Receptor for B Lymphocyte Stimulator that is Mutated in a Mouse Strain with Severe B Cell Deficiency”Curr. Biol., 11:1547-1552 (2001).
Yu et al., “APRIL and TALL-1 and Receptors BCMA and TACI: System for Regulating Humoral Immunity”Nature Immunology, 1:252-256 (2000).
Gras et al., “BCMAp: an integral membrane protein in the Golgi apparatus of human mature B lymophocytes,”Int. Immunolgy 7(7):1093-1106 (1995).
Hahne et al., “Apr., a new ligand of the tumor necrosis family, stimulates tumor cell growth,”J. Exp. Med 188(6):1185-1190 (1998).
Kayagaki et al. “BAFF/BLyS Receptor 3 Binds the B Cell Survival Factor BAFF Ligand through a Discrete Surface Loop and Promotes Processing of NF-κB2,”Immunity 10:515-524 (2002).
Khare et al., “The role of TALL-1 and Apr. in immune regulations,”Trends Immunol. 22(2):61-63 (2001).
Khare et al., “Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice,”PNAS 97(7):3370-3375 (2000).
Laabi et al., “The BCMA gene, preferentially expressed during B lymphoid maturation, 13 bidirectionally transcribed,”Nucleic Acids Res. 22(7):1147-1154 (1994).
Laabi et al., “The new gene, BCM, on chromosome 16 is fused to the interleukin 2 gene by a t(4;16)(q26,p13) translocation in a malignant T cell lymphoma,”EMBO J. 11:3897-3904 (1992).
Mackay et al., “Mice Transgenic for BAFF Develop Lymphocyte Disorders Along with Autoimmune Manifestations,”J. Exp. Med 190(11):1697-1710 (1999).
Madry et al., “The characterization of murine BCMA gene defines it as a new member of the tumor necrosiss factor receptor superfamily,”Int. Immunol. 10(11):1693-1702 (1998).
Moore et al., “BlyS, Member of the Tumor Necrosis Factor Family and B Lymphocyte Stimulator,”Science 282:260-263 (1999).
Shu et al., “TALL-1 is a novel member of the TNF family that is down-regulated by mitogens,”J. Leukocyte Biol. 65:680-683 (1999).
Wu et al., “Tumor Necrosis Factor (TNF) Receptor Superfamily Member TACI is a High Affinity Receptor of TNF Family Members Apr. and BlyS,”J. Biol. Chem. 275(45):35478-35485 (2000).
Riken Genome Exploration Research Group Phase II Team and Fantom Consortium “Functional annotation of full-length mouse cDNA collection”Nature, Feb. 8, 2001, pp. 685-690, vol. 409, Macmillan Magazine Ltd. United KIngdom.
Excerpt from Supplementary Table 1 to : Riken Genome Exploration Research Group Phase II Team and Fantom Consortium “Functional annotation of a full-length mouse cDNA collection”Nature, Feb. 8, 2001, pp. 685-690, vol. 409, Macmillan Magazine Ltd., United Kingdom.
Do et al., “Attenuation of Apoptosis Underlies B Lymphocyte Simulator Enhancement of Humoral Immune Response,”J. Exp. Med. 192(7):953-964 (2000).
GenBank AccessionNo. AK008142, Published Feb. 16, 2001.
Gordon et al., “BAFF/Blys Receptor 3 Comprises a Minimal TNF Receptor-Like Module that Encodes a Highly Focused Ligand-Binding Site,”Biochemistry 42:5977-5983 (2003).
Ambrose Christine M.
Thompson Jeffrey S.
Biogen Idec MA Inc.
Cox Niki D.
Linnik Konstantin M.
McDonell Leslie A.
O'Hara Eileen B.
LandOfFree
Nucleic acids encoding BAFF receptor, chimeric proteins and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleic acids encoding BAFF receptor, chimeric proteins and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acids encoding BAFF receptor, chimeric proteins and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3616966